97 related articles for article (PubMed ID: 8499154)
1. Hormonal therapy for metastatic renal cell carcinoma combined androgen and provera followed by high dose tamoxifen.
Papac RJ; Keohane MF
Eur J Cancer; 1993; 29A(7):997-9. PubMed ID: 8499154
[TBL] [Abstract][Full Text] [Related]
2. [Complete regression of pulmonary metastases from renal cell carcinoma induced by medroxyprogesterone and streptococcal preparation: a case presentation].
Nagakura K; Takao M; Matsuzaki S; Ieda K
Nihon Hinyokika Gakkai Zasshi; 1985 Dec; 76(12):1909-13. PubMed ID: 2940397
[No Abstract] [Full Text] [Related]
3. Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
Whitney CW; Brunetto VL; Zaino RJ; Lentz SS; Sorosky J; Armstrong DK; Lee RB;
Gynecol Oncol; 2004 Jan; 92(1):4-9. PubMed ID: 14751130
[TBL] [Abstract][Full Text] [Related]
4. Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.
Stahl M; Schmoll E; Becker H; Schlichter A; Hoffmann L; Wagner H; Possinger K; Müller W; Köllermann M; Weidenhammer W
Semin Oncol; 1991 Apr; 18(2 Suppl 4):33-7. PubMed ID: 2031196
[TBL] [Abstract][Full Text] [Related]
5. Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen.
Henriksson R; Nilsson S; Colleen S; Wersäll P; Helsing M; Zimmerman R; Engman K
Br J Cancer; 1998 Apr; 77(8):1311-7. PubMed ID: 9579838
[TBL] [Abstract][Full Text] [Related]
6. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
7. Metastatic renal cell carcinoma arising in a congenital solitary kidney. Treatment with interferon-containing combinations. A case report and a review of the literature.
Merimsky O; Laufer R; Chaitchik S
J Urol (Paris); 1989; 95(4):243-5. PubMed ID: 2529317
[TBL] [Abstract][Full Text] [Related]
8. [A combined chemo-endocrine therapy of advanced renal cell carcinoma].
Wada T; Yasutomi M; Abe T; Wada A
Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2294-8. PubMed ID: 3128617
[No Abstract] [Full Text] [Related]
9. [A combined chemo-endocrine therapy with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma].
Wada T; Morikawa E; Yasutomi M; Takagi H; Aizawa M; Abe T; Wada A
Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1652-6. PubMed ID: 2230447
[TBL] [Abstract][Full Text] [Related]
10. [Mammary gland carcinoma treated by large-dose medroxyprogesterone acetate of which pulmonary metastases disappeared and a selection of hormone, chemoimmunological treatment].
Matsumoto S; Kutsuna T; Tann M; Mizuno Y; Shinohara M; Kimura T; Banno T; Yoshizaki S
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2457-9. PubMed ID: 2526619
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II study.
Liu JH; Yang MH; Fan FS; Yen CC; Wang WS; Chang YH; Chen KK; Chen PM
Urology; 2001 Apr; 57(4):650-4. PubMed ID: 11306370
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma.
Stahl M; Wilke H; Schmoll HJ; Schöber C; Diedrich H; Casper J; Freund M; Poliwoda H
Ann Oncol; 1992 Feb; 3(2):167-8. PubMed ID: 1606089
[TBL] [Abstract][Full Text] [Related]
13. Combined chemoendocrine treatment with tegafur and tamoxifen for advanced renal cell carcinoma.
Wada T; Nishiyama K; Maeda M; Hara S; Tanaka N; Yasutomi M; Kurita T
Anticancer Res; 1995; 15(4):1581-4. PubMed ID: 7654050
[TBL] [Abstract][Full Text] [Related]
14. Cimetidine and coumarin therapy of renal cell carcinoma. A pilot study.
Kokron O; Maca S; Gasser G; Schmidt PR
Oncology; 1991; 48(2):102-6. PubMed ID: 1997930
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.
Dutcher JP; Logan T; Gordon M; Sosman J; Weiss G; Margolin K; Plasse T; Mier J; Lotze M; Clark J; Atkins M
Clin Cancer Res; 2000 Sep; 6(9):3442-50. PubMed ID: 10999727
[TBL] [Abstract][Full Text] [Related]
16. A combined chemo-endocrine treatment with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma.
Wada T; Houjou T; Kubo R; Yasutomi M; Kurita T
Anticancer Res; 1993; 13(6B):2465-7. PubMed ID: 8135483
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta].
Schenck M; Börgermann C; Jäger T; vom Dorp F; Sperling H; Rübben H; Lümmen G
Urologe A; 2007 May; 46(5):528-34. PubMed ID: 17356836
[TBL] [Abstract][Full Text] [Related]
18. IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial.
Atzpodien J; Kirchner H; Illiger HJ; Metzner B; Ukena D; Schott H; Funke PJ; Gramatzki M; Jürgenson S; Wandert T; Patzelt T; Reitz M
Br J Cancer; 2001 Oct; 85(8):1130-6. PubMed ID: 11710825
[TBL] [Abstract][Full Text] [Related]
19. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
[TBL] [Abstract][Full Text] [Related]
20. High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma.
Yang CH; Cheng AL; Yeh KH; Yu CJ; Lin JF; Yang PC
Cancer; 1999 Aug; 86(3):415-20. PubMed ID: 10430249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
